ad

Tatva Chintan Pharma Chem Ltd. (TATVA): Tatva Chintan Pharma Chem Share Price near 52-Week High as stock trades at Rs 1,823.50

28 Sept 2026 • 9:34 am

Tatva Chintan Pharma Chem Ltd. (TATVA): Tatva Chintan Pharma Chem Share Price near 52-Week High as stock trades at Rs 1,823.50
Tatva Chintan Pharma Chem Ltd. (TATVA) share price is trading within 2% of its 52-week high today and stood at Rs 1,823.5, up 1.8% from the previous close. Market cap was Rs 4,189.98 crore.

Tatva Chintan Pharma Chem Share Price is trading at Rs 1,823.50, up 1.80% today and near its 52-week high, with market capitalisation at Rs 4,189.98 Cr as of 28 September 2026 at 9:26 AM IST.

Tatva Chintan Pharma Chem Share Price is at Rs 1,823.50, up Rs 32.30 from the previous close of Rs 1,791.20, and the stock is trading close to its 52-week high on 28 September 2026 at 9:26 AM IST. The company’s market capitalisation stands at Rs 4,189.98 Cr, which places Tatva Chintan Pharma Chem Share Price firmly in the spotlight for Tatva Chintan Pharma Chem Share Price Today, Tatva Chintan Pharma Chem Stock News and Tatva Chintan Pharma Chem Share Price Live searches.

Tatva Chintan Pharma Chem Share Price Today: Price Action Analysis

The latest Univest data shows that Tatva Chintan Pharma Chem Share Price moved from an opening level of Rs 1,809 to a day high of Rs 1,880.45 and a day low of Rs 1,809. That keeps the stock within a narrow band around the current yearly high zone. The available numbers confirm the price event but do not establish a company-specific catalyst. For readers tracking Tatva Chintan Pharma Chem Share Price Today, the key question is how the current valuation and the chemicals sector comparison line up with the recent price strength.

In Tatva Chintan Pharma Chem Stock News, the move matters because the stock is already trading near its one-year high while the broader information set shows a premium valuation versus the chemicals industry benchmark. That combination keeps Tatva Chintan Pharma Chem Share Price in focus for investors following Tatva Chintan Pharma Chem Share Price Update, Tatva Chintan Pharma Chem Latest News and Tatva Chintan Pharma Chem Stock Analysis on Univest.

Metric Value
Current Price Rs 1,823.5
Previous Close Rs 1,791.2
Today's Move +Rs 32.3 (+1.8%)
Open Rs 1,809
High Rs 1,880.45
Low Rs 1,809
Market Capitalisation Rs 4,189.98 crore

Tatva Chintan Pharma Chem Ltd. (TATVA) traded at Rs 1,823.5 versus the previous close of Rs 1,791.2, a rise of 1.8%. The stock opened at Rs 1,809, reached a high of Rs 1,880.45 and touched a low of Rs 1,809.

Tatva Chintan Pharma Chem Share Price Today reflects a gain of Rs 32.30, or 1.80%, against the previous close. The stock traded at Rs 1,823.50 after opening at Rs 1,809 and reaching Rs 1,880.45 in the day’s range. That places Tatva Chintan Pharma Chem Share Price near its 52-week high and keeps the one-year high theme central to Tatva Chintan Pharma Chem Share News today.

The day low was also Rs 1,809, which means the opening level matched the lowest point seen in the recorded range so far. For Tatva Chintan Pharma Chem Share Price Today, that range shows that the stock has stayed close to its upper area through the morning snapshot. The event is a Tatva Chintan Pharma Chem 52 Week High story because the price is trading within 2% of the yearly peak, yet the numbers alone do not explain the reason behind the move. Readers following Tatva Chintan Pharma Chem NSE and Tatva Chintan Pharma Chem BSE should therefore focus on the price event itself and the company metrics that accompany it.

For Stock Market Today and Share Market Today searches, Tatva Chintan Pharma Chem Share Price stands out as one of the 52 Week High Stocks in chemicals. The move is concrete, measurable and current, which makes Tatva Chintan Pharma Chem Share Price Today and Tatva Chintan Pharma Chem Stock Updates relevant for market watchers seeking verified price action rather than speculation.

Tatva Chintan Pharma Chem Ltd. (TATVA) Fundamental Analysis

Metric Value
Market Capitalisation Rs 4,189.98 crore
P/E Ratio 81.54x
P/B Ratio 5.25x
ROE 5.53%
ROCE 7.17%
EPS Rs 21.97
Book Value Per Share Rs 341.03
Dividend Yield 0.11%

Tatva Chintan Pharma Chem Ltd. (TATVA) fundamental metrics show P/E 81.54x, P/B 5.25x, ROE 5.53%, ROCE 7.17%. These figures provide context only and are not a buy or sell signal.

Tatva Chintan Pharma Chem Ltd. has a market capitalisation of Rs 4189.98 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 81.54x, P/B at 5.25x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 5.53% and ROCE of 7.17%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 21.97, book value per share of Rs 341.03, dividend yield of 0.11%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 22.13x, median ROE of 7.74%, median ROCE of 9.97%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Chemicals
Industry Chemicals
Benchmark Scope same industry
Company P/E Ratio 81.54x
Benchmark Median P/E 22.13x
Benchmark Average P/E 42.91x
Benchmark P/E Range 0x to 765.18x
Company P/B Ratio 5.25x
Benchmark Median P/B 1.93x
Company ROE 5.53%
Benchmark Median ROE 7.74%
Company ROCE 7.17%
Benchmark Median ROCE 9.97%
Company Market Capitalisation Rs 4,189.98 crore
Benchmark Median Market Cap Rs 445.71 crore

Tatva Chintan Pharma Chem Ltd. (TATVA) is classified under sector: Chemicals and industry: Chemicals.

Tatva Chintan Pharma Chem Ltd. (TATVA) has a P/E ratio of 81.54x, which is above the benchmark median of 22.13x, a difference of +268.46%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Tatva Chintan Pharma Chem Ltd. (TATVA) has a ROE of 5.53%, which is below the benchmark median of 7.74%, a difference of -28.55%. Tatva Chintan Pharma Chem Ltd. (TATVA) has a ROCE of 7.17%, which is below the benchmark median of 9.97%, a difference of -28.08%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Grauer & Weil (India) Ltd. GRAUWEIL 3,996.82 24.95 3.56 16.23 21.55
GHCL Ltd. GHCL 3,868.57 8.19 1.09 13.46 18.12
Epigral Ltd. EPIGRAL 4,574.06 16.88 1.97 16.09 15.65
Gujarat Alkalies And Chemicals Ltd. GUJALKALI 4,632.03 69.81 0.88 -0.04 1.4
Vishnu Chemicals Ltd. VISHNU 4,706.01 31.44 4.24 14.26 16.38

Tatva Chintan Pharma Chem Ltd. (TATVA) has a P/E ratio of 81.54x compared with the displayed peer median of 24.95x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 5.53% compares with a peer median of 14.26% across the companies shown in the table. ROCE stood at 7.17% versus the displayed peer median of 16.38%, providing a capital-efficiency comparison. Tatva Chintan Pharma Chem Ltd. (TATVA) has a market capitalisation of Rs 4,189.98 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Tatva Chintan Pharma Chem

  • Tatva Chintan Pharma Chem Share Price is at Rs 1,823.50 and is trading near its 52-week high.
  • The stock is up Rs 32.30, or 1.80%, versus the previous close of Rs 1,791.20.
  • Market capitalisation stands at Rs 4,189.98 Cr for Tatva Chintan Pharma Chem Share Price.
  • The P/E ratio of 81.54 is above the chemicals benchmark median of 22.13.
  • ROE of 5.53% and ROCE of 7.17% sit below the benchmark medians in the same-industry set.

About Tatva Chintan Pharma Chem

Tatva Chintan Pharma Chem Ltd. operates in the Chemicals sector and Chemicals industry. That classification is the core company profile available for Tatva Chintan Pharma Chem Share Price coverage today. For readers following Tatva Chintan Pharma Chem Company News, Tatva Chintan Pharma Chem Share Price Today and Tatva Chintan Pharma Chem Market Cap, the company sits in a chemicals peer set where valuation and return ratios vary widely across listed names. Univest tracks Tatva Chintan Pharma Chem Share Price alongside the broader chemical industry context so that the stock can be viewed within its correct market segment.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.

Frequently Asked Questions

Why is Tatva Chintan Pharma Chem Share Price in focus today?

Ans. Tatva Chintan Pharma Chem Share Price is in focus because it is trading near its 52-week high at Rs 1,823.50. The move comes with market capitalisation at Rs 4,189.98 Cr and a fresh price update.

What is Tatva Chintan Pharma Chem Share Price today?

Ans. Tatva Chintan Pharma Chem Share Price is Rs 1,823.50. It is up Rs 32.30, or 1.80%, from the previous close of Rs 1,791.20, and it traded between Rs 1,809 and Rs 1,880.45.

Is Tatva Chintan Pharma Chem trading near its 52-week high?

Ans. Yes. Tatva Chintan Pharma Chem Share Price is trading close to its 52-week high and remains within 2% of that yearly peak. That makes the price event important for Share Price Today tracking.

What does Tatva Chintan Pharma Chem Fundamental Analysis show?

Ans. Tatva Chintan Pharma Chem Fundamental Analysis shows P/E of 81.54, P/B of 5.25, ROE of 5.53%, ROCE of 7.17%, EPS of Rs 21.97 and book value of Rs 341.03. Those numbers define the current valuation.

How does Tatva Chintan Pharma Chem compare with chemicals peers?

Ans. In the peer set, Tatva Chintan Pharma Chem Share Price carries a higher P/E than the listed comparables shown here. Its ROE and ROCE are lower than several peers, while its market cap sits in the same broad band.

What is the sector view for Tatva Chintan Pharma Chem Share Price?

Ans. The chemicals sector comparison shows Tatva Chintan Pharma Chem Share Price with a P/E above the industry median and average. ROE and ROCE are below the same-industry medians, so the sector context remains mixed.

Does Tatva Chintan Pharma Chem pay a dividend?

Ans. Tatva Chintan Pharma Chem Share Price data shows a dividend yield of 0.11%. That is part of the current valuation picture, alongside EPS, book value and the market capitalisation of Rs 4,189.98 Cr.

Where can I track Tatva Chintan Pharma Chem Share Price on Univest?

Ans. Univest tracks Tatva Chintan Pharma Chem Share Price, price updates, market capitalisation, valuation ratios, sector comparison and stock news in one place. It is useful for readers following Tatva Chintan Pharma Chem Stock News and Share Price Live.

Track Tatva Chintan Pharma Chem Share Price on Univest

Use Tatva Chintan Pharma Chem Ltd. (TATVA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track Tatva Chintan Pharma Chem Share Price on Univest for live price movement, market capitalisation, financial ratios, sector context, peer comparison and event-led stock news. Univest also helps readers follow Tatva Chintan Pharma Chem Share Price Today, Tatva Chintan Pharma Chem Stock News and Tatva Chintan Pharma Chem Share Price Update in one place.

From Tatva Chintan Pharma Chem Share Price Live checks to Tatva Chintan Pharma Chem Fundamental Analysis and Tatva Chintan Pharma Chem Stock Performance, Univest keeps the latest market context organised for readers who want verified numbers and simple comparisons.

Tatva Chintan Pharma Chem Share Price near 52-week high on Univest

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down